The Contagion Skin & Soft Tissues Diseases specialty page provides skin & soft tissue-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
Edmond LaVoie, PhD, professor and chair, Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers University, co-founder of TAXIS Pharmaceuticals, and co-author of the study on the new MRSA drug, TXA709, explains how TXA709 targets MRSA differently than other antibiotics.
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the prevalence of skin and soft tissue infections in the United States.
Elimination of viral hepatitis depends on individuals actively participating in their own healthcare and management. They can only do this if they understand why and how to protect their miraculous, life-sustaining liver from harm. Education is the key to
Contagion® is a fully-integrated print and digital news publication that provides practitioners and specialists working in infectious disease with up-to-date disease-specific information designed to improve patient outcomes and positively impact the identification, diagnosis, treatment, and prevention of infectious diseases.
2 Clarke Drive
Cranbury, NJ 08512